secwatch.observer — SEC 8-K summary
======================================

Issuer:     OS Therapies Inc (OSTX)
CIK:        0001795091
Form:       8-K
Filed at:   2025-08-15T23:59:59+00:00
Accession:  0001213900-25-077431
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

OS Therapies amends bylaws to reduce stockholder meeting quorum to one-third of voting power
--------------------------------------------------------------------------------

- Board approved amendment to Section 3.10 of Article III of the Bylaws on August 15, 2025.
- Quorum for stockholder meetings changed to one-third of the voting power of outstanding shares entitled to vote, present in person or by proxy.
- Amendment filed as Exhibit 3.1 via prospectus supplement on Form S-3ASR; no sale of securities by DoD is implied.
- No proceeds to company; DoD may convert preferred stock or exercise warrant to receive up to 24,521,672 common shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1795091/000121390025077431/0001213900-25-077431-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1795091/000121390025077431/ea0253338-8k_ostherap.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-077431

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer